Foghorn Therapeutics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Foghorn Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $9.00K, a 96.46% decline year-over-year.
- Foghorn Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $89.00K, a 35.97% decline year-over-year.
- Foghorn Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $49.00K, a 96.60% decline year-over-year.
- Foghorn Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $254.00K.
- Foghorn Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $483.00K, a 81.51% decline from fiscal 2024.
- Foghorn Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $2.61M, a 46.91% increase from fiscal 2023.
- Foghorn Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $1.78M, a 0.85% increase from fiscal 2022.
- Foghorn Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $1.76M, a 24.33% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $9.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $89.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $483.00K 10-K · filed 2026-03-11 | |
| 2025-09-30 | $49.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $254.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $139.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $2.61M 10-K · filed 2026-03-11 | |
| 2024-09-30 | $1.44M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.17M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $1.78M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $1.39M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $102.00K 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $102.00K 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $1.76M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $334.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $1.03M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $384.00K 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $1.42M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $505.00K 10-Q · filed 2022-11-08 | $1.05M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $111.00K 10-Q · filed 2022-11-08 | $1.12M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-03-31 | $62.00K 10-Q · filed 2022-11-08 | $1.04M derived: sum of 4 quarters · filed 2022-11-08 |
| 2020-12-31 | $369.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $1.22M 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $578.00K 10-Q · filed 2021-11-09 | $1.35M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $27.00K 10-Q · filed 2021-11-09 | $912.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-03-31 | $247.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $691.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $138.00K 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |